Heron Therapeutics Inc. buy BiotechBee
Start price
08.01.24
/
70%
€1.70
Target price
30.09.25
€3.00
Performance (%)
-9.94%
End price
14.12.24
€1.53
Summary
This prediction ended on 14.12.24 with a price of €1.53. With a performance of -9.94%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Heron Therapeutics Inc. | -5.401% | -5.401% | -31.179% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
According to BiotechBee what are the pros and cons of Heron Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Heron Therapeutics Inc. diskutieren
In the thread Trading Heron Therapeutics Inc.
Stopped prediction by BiotechBee for Heron Therapeutics Inc.
Heron Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.12
24.06.23
24.06.23
€2.30
31.03.26
31.03.26
51.79%
08.01.24
08.01.24
Could be very worthwhile Investment >20% year
